Free Cash Flow Chart

View Free Cash Flow for NPCE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -11.61M
March 31, 2026 -9.836M
December 31, 2025 -11.34M
September 30, 2025 -16.58M
June 30, 2025 -16.43M
March 31, 2025 -18.14M
December 31, 2024 -18.26M
September 30, 2024 -16.79M
June 30, 2024 -17.28M
March 31, 2024 -17.68M
December 31, 2023 -19.87M
September 30, 2023 -24.45M
Date Value
June 30, 2023 -29.14M
March 31, 2023 -35.60M
December 31, 2022 -37.47M
September 30, 2022 -37.88M
June 30, 2022 -35.48M
March 31, 2022 -30.69M
December 31, 2021 -24.96M
September 30, 2021 -23.07M
June 30, 2021 -23.90M
March 31, 2021 -21.08M
December 31, 2020 -21.67M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Tandem Diabetes Care, Inc. -26.62M
CVRx, Inc. -41.05M
Accuray, Inc. -19.26M
Micron Solutions, Inc. --
Orthofix Medical, Inc. -26.93M